Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap41.66B
Enterprise Value44.27B
P/E Ratio23.33
PEG Ratio-0.7
Price/Sales Ratio4.5
Price/Book Ratio0.95
Enterprise/Revenue4.81
Enterprise/EBITDA21.08

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.19
Operating Margin0.22
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.04

Income Statement

Revenue7.35B
Revenue/Share1.04
Gross Profit2.69B
EBITDA1.82B
Net Income1.58B
Diluted EPS0.24

Balance Sheet

Total Cash1.88B
Total Cash/Share0.29
Total Debt3.95B
Total Debt/Equity0.12
Current Ratio3.73
Book Value Per Share4.94

Price History

52-Week Change-32.17
52-Week High7.26
52-Week Low4.18
Moving Average 50 Days5.04
Moving Average 200 Days6.02

Statistics

Average Volume45M
Shares Outstanding6.59B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.05
Trailing Annual Dividend Yield1.03
Payout Ratio0.13
Last Split Factor9:5
Last Split DateSeptember 28, 2016
AD